1. Home
  2. WRBY vs NVAX Comparison

WRBY vs NVAX Comparison

Compare WRBY & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$26.65

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.62

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
NVAX
Founded
2010
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.1B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
WRBY
NVAX
Price
$26.65
$6.62
Analyst Decision
Buy
Hold
Analyst Count
15
9
Target Price
$25.43
$10.78
AVG Volume (30 Days)
5.6M
3.3M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
2.07
Revenue
$850,580,000.00
$1,064,651,000.00
Revenue This Year
$15.47
$58.91
Revenue Next Year
$12.84
N/A
P/E Ratio
$10,776.66
$3.15
Revenue Growth
14.55
20.27
52 Week Low
$13.63
$5.01
52 Week High
$31.00
$11.55

Technical Indicators

Market Signals
Indicator
WRBY
NVAX
Relative Strength Index (RSI) 65.59 41.68
Support Level $25.78 $6.36
Resistance Level $27.96 $6.76
Average True Range (ATR) 2.00 0.22
MACD 0.67 0.04
Stochastic Oscillator 67.73 40.00

Price Performance

Historical Comparison
WRBY
NVAX

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: